Logo image of GIN.DE

GIVAUDAN-REG (GIN.DE) Stock Fundamental Analysis

FRA:GIN - Deutsche Boerse Ag - CH0010645932 - Common Stock - Currency: EUR

4521  +96 (+2.17%)

Fundamental Rating

6

GIN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 65 industry peers in the Chemicals industry. GIN scores excellent on profitability, but there are some minor concerns on its financial health. While showing a medium growth rate, GIN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year GIN was profitable.
In the past year GIN had a positive cash flow from operations.
In the past 5 years GIN has always been profitable.
GIN had a positive operating cash flow in each of the past 5 years.
GIN.DE Yearly Net Income VS EBIT VS OCF VS FCFGIN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

GIN has a better Return On Assets (9.01%) than 92.31% of its industry peers.
GIN has a Return On Equity of 23.81%. This is amongst the best in the industry. GIN outperforms 95.38% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.14%, GIN belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for GIN is above the industry average of 6.60%.
The last Return On Invested Capital (13.14%) for GIN is above the 3 year average (11.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.01%
ROE 23.81%
ROIC 13.14%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.29%
ROIC(5y)10.9%
GIN.DE Yearly ROA, ROE, ROICGIN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With an excellent Profit Margin value of 14.71%, GIN belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
In the last couple of years the Profit Margin of GIN has grown nicely.
GIN has a better Operating Margin (18.96%) than 92.31% of its industry peers.
GIN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 44.13%, GIN is in the better half of the industry, outperforming 63.08% of the companies in the same industry.
In the last couple of years the Gross Margin of GIN has grown nicely.
Industry RankSector Rank
OM 18.96%
PM (TTM) 14.71%
GM 44.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
GIN.DE Yearly Profit, Operating, Gross MarginsGIN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), GIN is creating value.
The number of shares outstanding for GIN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, GIN has more shares outstanding
The debt/assets ratio for GIN has been reduced compared to a year ago.
GIN.DE Yearly Shares OutstandingGIN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
GIN.DE Yearly Total Debt VS Total AssetsGIN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

GIN has an Altman-Z score of 5.06. This indicates that GIN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of GIN (5.06) is better than 87.69% of its industry peers.
The Debt to FCF ratio of GIN is 3.57, which is a good value as it means it would take GIN, 3.57 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.57, GIN belongs to the top of the industry, outperforming 86.15% of the companies in the same industry.
A Debt/Equity ratio of 0.86 indicates that GIN is somewhat dependend on debt financing.
GIN has a worse Debt to Equity ratio (0.86) than 72.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 3.57
Altman-Z 5.06
ROIC/WACC2.86
WACC4.6%
GIN.DE Yearly LT Debt VS Equity VS FCFGIN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

GIN has a Current Ratio of 1.49. This is a normal value and indicates that GIN is financially healthy and should not expect problems in meeting its short term obligations.
GIN's Current ratio of 1.49 is on the low side compared to the rest of the industry. GIN is outperformed by 64.62% of its industry peers.
A Quick Ratio of 0.98 indicates that GIN may have some problems paying its short term obligations.
With a Quick ratio value of 0.98, GIN is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
GIN does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 0.98
GIN.DE Yearly Current Assets VS Current LiabilitesGIN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.25% over the past year.
Measured over the past 5 years, GIN shows a small growth in Earnings Per Share. The EPS has been growing by 5.41% on average per year.
Looking at the last year, GIN shows a small growth in Revenue. The Revenue has grown by 7.19% in the last year.
GIN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.63% yearly.
EPS 1Y (TTM)15.25%
EPS 3Y10.02%
EPS 5Y5.41%
EPS Q2Q%1.73%
Revenue 1Y (TTM)7.19%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%8.73%

3.2 Future

The Earnings Per Share is expected to grow by 6.66% on average over the next years.
GIN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.25% yearly.
EPS Next Y9.8%
EPS Next 2Y7.85%
EPS Next 3Y7.57%
EPS Next 5Y6.66%
Revenue Next Year4.12%
Revenue Next 2Y4.29%
Revenue Next 3Y4.57%
Revenue Next 5Y5.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GIN.DE Yearly Revenue VS EstimatesGIN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
GIN.DE Yearly EPS VS EstimatesGIN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50 100 150

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 35.06, which means the current valuation is very expensive for GIN.
Compared to the rest of the industry, the Price/Earnings ratio of GIN is on the same level as its industry peers.
GIN is valuated rather expensively when we compare the Price/Earnings ratio to 26.43, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 31.93, GIN can be considered very expensive at the moment.
GIN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. GIN is more expensive than 67.69% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of GIN to the average of the S&P500 Index (22.17), we can say GIN is valued slightly more expensively.
Industry RankSector Rank
PE 35.06
Fwd PE 31.93
GIN.DE Price Earnings VS Forward Price EarningsGIN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GIN is valued a bit more expensive than 66.15% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GIN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 29.35
EV/EBITDA 24.16
GIN.DE Per share dataGIN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GIN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of GIN may justify a higher PE ratio.
PEG (NY)3.58
PEG (5Y)6.48
EPS Next 2Y7.85%
EPS Next 3Y7.57%

4

5. Dividend

5.1 Amount

GIN has a Yearly Dividend Yield of 1.70%.
Compared to an average industry Dividend Yield of 3.09, GIN has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.38, GIN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.7%

5.2 History

The dividend of GIN has a limited annual growth rate of 2.07%.
Dividend Growth(5Y)2.07%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

57.52% of the earnings are spent on dividend by GIN. This is a bit on the high side, but may be sustainable.
GIN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP57.52%
EPS Next 2Y7.85%
EPS Next 3Y7.57%
GIN.DE Yearly Income VS Free CF VS DividendGIN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
GIN.DE Dividend Payout.GIN.DE Dividend Payout, showing the Payout Ratio.GIN.DE Dividend Payout.PayoutRetained Earnings

GIVAUDAN-REG

FRA:GIN (6/4/2025, 7:00:00 PM)

4521

+96 (+2.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-10 2025-04-10
Earnings (Next)07-22 2025-07-22
Inst Owners34.34%
Inst Owner ChangeN/A
Ins Owners12.15%
Ins Owner ChangeN/A
Market Cap41.73B
Analysts67.14
Price Target4454.81 (-1.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.7%
Yearly Dividend72.75
Dividend Growth(5Y)2.07%
DP57.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 35.06
Fwd PE 31.93
P/S 5.28
P/FCF 29.35
P/OCF 24.06
P/B 8.54
P/tB N/A
EV/EBITDA 24.16
EPS(TTM)128.94
EY2.85%
EPS(NY)141.58
Fwd EY3.13%
FCF(TTM)154.01
FCFY3.41%
OCF(TTM)187.89
OCFY4.16%
SpS857.03
BVpS529.34
TBVpS-28.91
PEG (NY)3.58
PEG (5Y)6.48
Profitability
Industry RankSector Rank
ROA 9.01%
ROE 23.81%
ROCE 15.16%
ROIC 13.14%
ROICexc 14.32%
ROICexgc 33.12%
OM 18.96%
PM (TTM) 14.71%
GM 44.13%
FCFM 17.97%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.29%
ROIC(5y)10.9%
ROICexc(3y)12.12%
ROICexc(5y)11.56%
ROICexgc(3y)26.36%
ROICexgc(5y)25.23%
ROCE(3y)13.03%
ROCE(5y)12.58%
ROICexcg growth 3Y11.26%
ROICexcg growth 5Y9.01%
ROICexc growth 3Y9.76%
ROICexc growth 5Y7.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 3.57
Debt/EBITDA 2.23
Cap/Depr 81.62%
Cap/Sales 3.95%
Interest Coverage 15.27
Cash Conversion 92.12%
Profit Quality 122.2%
Current Ratio 1.49
Quick Ratio 0.98
Altman-Z 5.06
F-Score7
WACC4.6%
ROIC/WACC2.86
Cap/Depr(3y)97.93%
Cap/Depr(5y)83.59%
Cap/Sales(3y)4.95%
Cap/Sales(5y)4.45%
Profit Quality(3y)99.97%
Profit Quality(5y)111.02%
High Growth Momentum
Growth
EPS 1Y (TTM)15.25%
EPS 3Y10.02%
EPS 5Y5.41%
EPS Q2Q%1.73%
EPS Next Y9.8%
EPS Next 2Y7.85%
EPS Next 3Y7.57%
EPS Next 5Y6.66%
Revenue 1Y (TTM)7.19%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%8.73%
Revenue Next Year4.12%
Revenue Next 2Y4.29%
Revenue Next 3Y4.57%
Revenue Next 5Y5.25%
EBIT growth 1Y25.45%
EBIT growth 3Y8.37%
EBIT growth 5Y8.14%
EBIT Next Year30.52%
EBIT Next 3Y12.9%
EBIT Next 5Y10.46%
FCF growth 1Y45.57%
FCF growth 3Y8.88%
FCF growth 5Y10.3%
OCF growth 1Y18.35%
OCF growth 3Y8.06%
OCF growth 5Y7.42%